174 related articles for article (PubMed ID: 34111264)
1. Imaging Biomarkers of 1-Year Activity in Type 1 Macular Neovascularization.
Costanzo E; Parravano M; Giannini D; Borrelli E; Sacconi R; Querques G
Transl Vis Sci Technol; 2021 May; 10(6):18. PubMed ID: 34111264
[TBL] [Abstract][Full Text] [Related]
2. Quantitative Optical Coherence Tomography Angiography Parameters in Type 1 Macular Neovascularization Secondary to Age-Related Macular Degeneration.
Arrigo A; Aragona E; Di Nunzio C; Bandello F; Parodi MB
Transl Vis Sci Technol; 2020 Aug; 9(9):48. PubMed ID: 32934898
[TBL] [Abstract][Full Text] [Related]
3. OCTA Biomarker Search in Patients with nAMD: Influence of Retinal Fluid on Time-Dependent Biomarker Response.
Told R; Reumueller A; Schranz M; Brugger J; Weigert G; Reiter GS; Sacu S; Schmidt-Erfurth U
Curr Eye Res; 2023 Jun; 48(6):600-604. PubMed ID: 36891909
[TBL] [Abstract][Full Text] [Related]
4. Correlation of vascular and fluid-related parameters in neovascular age-related macular degeneration using deep learning.
Schranz M; Told R; Hacker V; Reiter GS; Reumueller A; Vogl WD; Bogunovic H; Sacu S; Schmidt-Erfurth U; Roberts PK
Acta Ophthalmol; 2023 Feb; 101(1):e95-e105. PubMed ID: 35912717
[TBL] [Abstract][Full Text] [Related]
5. Subretinal Hyperreflective Material (SHRM) as biomarker of activity in Exudative and Non- exudative inflammatory choroidal neovascularization.
Arora A; Agarwal A; Bansal R; Katoch D; Marchese A; Aggarwal K; Agrawal R; Gupta V
Ocul Immunol Inflamm; 2023 Jan; 31(1):48-55. PubMed ID: 34648411
[TBL] [Abstract][Full Text] [Related]
6. Optical coherence tomography angiography for detection of macular neovascularization associated with atrophy in age-related macular degeneration.
Corvi F; Cozzi M; Invernizzi A; Pace L; Sadda SR; Staurenghi G
Graefes Arch Clin Exp Ophthalmol; 2021 Feb; 259(2):291-299. PubMed ID: 32620993
[TBL] [Abstract][Full Text] [Related]
7. Optical coherence tomography angiography features of macular neovascularization in wet age-related macular degeneration: A cross-sectional study.
Ahmed M; Syrine BM; Nadia BA; Anis M; Karim Z; Mohamed G; Hachemi M; Fethi K; Leila K
Ann Med Surg (Lond); 2021 Oct; 70():102826. PubMed ID: 34540215
[TBL] [Abstract][Full Text] [Related]
8. Masking of macular neovascular membranes by subretinal hyperreflective material on optical coherence tomography angiography.
Fayed AE; Baddar D; Estawro RG; Gerges TK
Eur J Ophthalmol; 2022 Nov; 32(6):3547-3555. PubMed ID: 35243925
[TBL] [Abstract][Full Text] [Related]
9. Optical coherence tomography angiography for the detection of macular neovascularization-comparison of en face versus cross-sectional view.
Siggel R; Spital C; Lentzsch A; Liakopoulos S
Eye (Lond); 2023 Feb; 37(2):256-262. PubMed ID: 34992250
[TBL] [Abstract][Full Text] [Related]
10. Projection artifact removal improves visualization and quantitation of macular neovascularization imaged by optical coherence tomography angiography.
Zhang Q; Zhang A; Lee CS; Lee AY; Rezaei KA; Roisman L; Miller A; Zheng F; Gregori G; Durbin MK; An L; Stetson PF; Rosenfeld PJ; Wang RK
Ophthalmol Retina; 2017; 1(2):124-136. PubMed ID: 28584883
[TBL] [Abstract][Full Text] [Related]
11. The Architecture of Macular Neovascularizations Predicts Treatment Responses to Anti-VEGF Therapy in Neovascular AMD.
Faatz H; Rothaus K; Ziegler M; Book M; Spital G; Lange C; Lommatzsch A
Diagnostics (Basel); 2022 Nov; 12(11):. PubMed ID: 36428867
[TBL] [Abstract][Full Text] [Related]
12. Comparison of swept-source versus spectral-domain optical coherence tomography angiography for detection of macular neovascularization.
Lentzsch A; Schöllhorn L; Schnorr C; Siggel R; Liakopoulos S
Graefes Arch Clin Exp Ophthalmol; 2022 Jan; 260(1):113-119. PubMed ID: 34226972
[TBL] [Abstract][Full Text] [Related]
13. Macular neovascularization in AMD, CSC and best vitelliform macular dystrophy: quantitative OCTA detects distinct clinical entities.
Arrigo A; Bordato A; Aragona E; Amato A; Viganò C; Bandello F; Battaglia Parodi M
Eye (Lond); 2021 Dec; 35(12):3266-3276. PubMed ID: 33495568
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers of macular neovascularisation activity using optical coherence tomography angiography in treated stable neovascular age related macular degeneration.
Hanumunthadu D; Saleh A; Florea D; Balaskas K; Keane PA; Aslam T; Patel PJ
BMC Ophthalmol; 2023 Feb; 23(1):68. PubMed ID: 36782163
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Imaging Biomarkers in Diabetic Macular Edema Eyes Treated with Intravitreal Dexamethasone Implant.
Costanzo E; Giannini D; De Geronimo D; Fragiotta S; Varano M; Parravano M
J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36835839
[TBL] [Abstract][Full Text] [Related]
16. Optical Coherence Tomography Angiography Quantitative Assessment of Macular Neovascularization in Best Vitelliform Macular Dystrophy.
Parodi MB; Arrigo A; Bandello F
Invest Ophthalmol Vis Sci; 2020 Jun; 61(6):61. PubMed ID: 32602906
[TBL] [Abstract][Full Text] [Related]
17. Morphological and Functional Relationship Between OCTA and FA/ICGA Quantitative Features in AMD-Related Macular Neovascularization.
Arrigo A; Aragona E; Bordato A; Amato A; Borghesan F; Bandello F; Battaglia Parodi M
Front Med (Lausanne); 2021; 8():758668. PubMed ID: 34746193
[No Abstract] [Full Text] [Related]
18. Presence or absence of choroidal hyper-transmission by SD-OCT imaging distinguishes inflammatory from neovascular lesions in myopic eyes.
Shi X; Cai Y; Luo X; Liang S; Rosenfeld PJ; Li X
Graefes Arch Clin Exp Ophthalmol; 2020 Apr; 258(4):751-758. PubMed ID: 31907643
[TBL] [Abstract][Full Text] [Related]
19. Identification of macular neovascularization in central serous chorioretinopathy using swept-source OCT angiography.
Staropoli PC; Iyer P; Gregori G; Rosenfeld PJ; Flynn HW
Am J Ophthalmol Case Rep; 2023 Jun; 30():101843. PubMed ID: 37092114
[TBL] [Abstract][Full Text] [Related]
20. Color Fundus Autofluorescence to Determine Activity of Macular Neovascularization in Age-Related Macular Degeneration.
Vujosevic S; Toma C; Sarao V; Veritti D; Brambilla M; Muraca A; De Cillà S; Villani E; Nucci P; Lanzetta P
Transl Vis Sci Technol; 2021 Feb; 10(2):33. PubMed ID: 34003918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
